Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes — Stella

Home/Type 2 Diabets Mellitus/Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabets Mellitus trials

Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

South Korea

Seoul National University Bundang Hospital, Seongnam-si

Key details

Phase

Large-scale testing

Sponsor

Seoul National University Bundang Hospital

Collaborators

SK Chemicals Co., Ltd.

Enrollment target

~80 participants

Started

January 2025

Primary completion

December 2026

Age range

60 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.